Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline fumarate tablets in Chinese adults with multidrug-resistant pulmonary tuberculosis
CTR20260500Phase 4Active
- Sponsor
- Beijing Fuyuan Pharmaceutical
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bedaquiline in pulmonary tuberculosis (TB), sponsored by Beijing Fuyuan Pharmaceutical. Started Apr 2026; status: active.
02
Drugs
bedaquiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20260500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260500.